Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A 14-Day Randomized Double-Blind Comparative Viral Kinetic Study of Elvucitabine
2006-005968-13Phase 2Completed
- Sponsor
- Achillion Pharmaceuticals
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of elvucitabine in Human immunodeficiency virus infection type 1 (2 arms), sponsored by Achillion Pharmaceuticals. Primary endpoint: Primary efficacy endpoint. Started Mar 2007; status: completed.
02
Drugs
elvucitabine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2006-005968-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005968-13.